Stryker Corporation is the second-largest medical device company on the market according to recent reports, despite serious troubles with two major metal hip implant devices. Stryker recently reached a faulty hip replacement settlement totaling more than $1.4 billion.
Stryker’s Rejuvenate and ABG II metal-on-metal hip replacements were recalled in 2012 after studies showed the devices were much more likely to fail than alternatives. Thousands of patients who received one of the defective implants filed Stryker lawsuits alleging they suffered severe side effects, including tissue damage and toxic levels of metal in the blood stream.
The Stryker settlement covers thousands of patients who required revision surgery as a result of their hip replacement injuries. However, patients may still be eligible to file separate Stryker lawsuits against the company if they suffered complications due to the Rejuvenate or ABG II hip implants.